The DOI matches its Crossref record; 192 of the 192 references it cites were found in a registry or an index.
Update on melatonin receptors: IUPHAR Review 20
Open accessAbstract
Melatonin receptors are seven transmembrane‐spanning proteins belonging to the GPCR superfamily. In mammals, two melatonin receptor subtypes exist ‐ MT 1 and MT 2‐ encoded by the MTNR1A and MTNR1B genes respectively. The current review provides an update on melatonin receptors by the corresponding subcommittee of the International Union of Basic and Clinical Pharmacology. We will highlight recent developments of melatonin receptor ligands, including radioligands, and give an update on the latest phenotyping results of melatonin receptor knockout mice. The current status and perspectives of the structure of melatonin receptor will be summarized. The physiological importance of melatonin receptor dimers and biologically important and type 2 diabetes‐associated genetic variants of melatonin receptors will be discussed. The role of melatonin receptors in physiology and disease will be further exemplified by their functions in the immune system and the CNS. Finally, antioxidant and free radical scavenger properties of melatonin and its relation to melatonin receptors will be critically addressed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An integrated map of genetic variation from 1,092 human genomes
The 1000 Genomes Project Consortium (2012) · Nature · doi:10.1038/nature11632 · Cited by 7,711
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Trong, I. L., Teller, D. C., Okada, T., Stenkamp, R. E., et al. (2000) · Science · doi:10.1126/science.289.5480.739 · Cited by 5,637
Crystal structure of the β2 adrenergic receptor–Gs protein complex
Rasmussen, S. G. F., DeVree, B. T., Zou, Y., Kruse, A. C., Chung, K. Y., Kobilka, T. S., Thian, F. S., Chae, P. S., Pardon, E., Calinski, D., et al. (2011) · Nature · doi:10.1038/nature10361 · Cited by 3,009
Structure of a nanobody-stabilized active state of the β2 adrenoceptor
Rasmussen, S. G. F., Choi, H.-J., Fung, J. J., Pardon, E., Casarosa, P., Chae, P. S., DeVree, B. T., Rosenbaum, D. M., Thian, F. S., Kobilka, T. S., et al. (2011) · Nature · doi:10.1038/nature09648 · Cited by 1,680
Tan, D., Manchester, L. C., Terron, M. P., Flores, L. J., & Reiter, R. J. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2006.00407.x · Cited by 1,601
Crystal structure of opsin in its G-protein-interacting conformation
Scheerer, P., Park, J. H., Hildebrand, P. W., Kim, Y. J., Krauß, N., Choe, H.-W., Hofmann, K. P., & Ernst, O. P. (2008) · Nature · doi:10.1038/nature07330 · Cited by 1,059
The Retinal Conformation and its Environment in Rhodopsin in Light of a New 2.2 Å Crystal Structure
Okada, T., Sugihara, M., Bondar, A.-N., Elstner, M., Entel, P., & Buss, V. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.07.044 · Cited by 1,049
Southan, C., Sharman, J. L., Benson, H. E., Faccenda, E., Pawson, A. J., Alexander, S. P. H., Buneman, O. P., Davenport, A. P., McGrath, J. C., Peters, J. A., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1037 · Cited by 1,035
The Concise Guide to PHARMACOLOGY 2015/16: G protein‐coupled receptors
Alexander, S. P., Davenport, A. P., Kelly, E., Marrion, N., Peters, J. A., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Southan, C., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13348 · Cited by 851
Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser
Kang, Y., Zhou, X. E., Gao, X., He, Y., Liu, W., Ishchenko, A., Barty, A., White, T. A., Yefanov, O., Han, G. W., et al. (2015) · Nature · doi:10.1038/nature14656 · Cited by 807
Variants in MTNR1B influence fasting glucose levels
Prokopenko, I., Langenberg, C., Florez, J. C., Saxena, R., Soranzo, N., Thorleifsson, G., Loos, R. J. F., Manning, A. K., Jackson, A. U., Aulchenko, Y., et al. (2009) · Nature Genetics · doi:10.1038/ng.290 · Cited by 744
Lyssenko, V., Nagorny, C. L. F., Erdos, M. R., Wierup, N., Jonsson, A., Spégel, P., Bugliani, M., Saxena, R., Fex, M., Pulizzi, N., et al. (2009) · Nature Genetics · doi:10.1038/ng.288 · Cited by 742
Melatonin: Buffering the Immune System
Carrillo-Vico, A., Lardone, P., Álvarez-Sánchez, N., Rodríguez-Rodríguez, A., & Guerrero, J. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14048638 · Cited by 740
Molecular Dissection of Two Distinct Actions of Melatonin on the Suprachiasmatic Circadian Clock
Liu, C., Weaver, D. R., Jin, X., Shearman, L. P., Pieschl, R. L., Gribkoff, V. K., & Reppert, S. M. (1997) · Neuron · doi:10.1016/s0896-6273(00)80350-5 · Cited by 723
Melatonin as a Potent and Inducible Endogenous Antioxidant: Synthesis and Metabolism
Tan, D.-X., Manchester, L., Esteban-Zubero, E., Zhou, Z., & Reiter, R. (2015) · Molecules · doi:10.3390/molecules201018886 · Cited by 719
Functional role of internal water molecules in rhodopsin revealed by x-ray crystallography
Okada, T., Fujiyoshi, Y., Silow, M., Navarro, J., Landau, E. M., & Shichida, Y. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082666399 · Cited by 662
An abundance of rare functional variants in 202 drug target genes sequenced in 14,002 people
Nelson, M. R., Wegmann, D., Ehm, M. G., Kessner, D., St. Jean, P., Verzilli, C., Shen, J., Tang, Z., Bacanu, S.-A., Fraser, D., et al. (2012) · Science · doi:10.1126/science.1217876 · Cited by 647
MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective
Liu, J., Clough, S. J., Hutchinson, A. J., Adamah-Biassi, E. B., Popovska-Gorevski, M., & Dubocovich, M. L. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124742 · Cited by 630
Self-citationDubocovich, M. L., Delagrange, P., Krause, D. N., Sugden, D., Cardinali, D. P., & Olcese, J. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.002832 · Cited by 621
Self-citationBouatia-Naji, N., Bonnefond, A., Cavalcanti-Proença, C., Sparsø, T., Holmkvist, J., Marchand, M., Delplanque, J., Lobbens, S., Rocheleau, G., Durand, E., et al. (2009) · Nature Genetics · doi:10.1038/ng.277 · Cited by 611
The Concise Guide to PHARMACOLOGY 2015/16: Enzymes
Alexander, S. P., Fabbro, D., Kelly, E., Marrion, N., Peters, J. A., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Southan, C., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13354 · Cited by 604
Identification of the Melatonin-binding SiteMT 3 as the Quinone Reductase 2
Nosjean, O., Ferro, M., Cogé, F., Beauverger, P., Henlin, J.-M., Lefoulon, F., Fauchère, J.-L., Delagrange, P., Canet, E., & Boutin, J. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005141200 · Cited by 603
Self-citationAgomelatine, the first melatonergic antidepressant: discovery, characterization and development
de Bodinat, C., Guardiola-Lemaitre, B., Mocaër, E., Renard, P., Muñoz, C., & Millan, M. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3140 · Cited by 593
G Protein–Coupled Receptor Oligomerization Revisited: Functional and Pharmacological Perspectives
Ferré, S., Casadó, V., Devi, L. A., Filizola, M., Jockers, R., Lohse, M. J., Milligan, G., Pin, J.-P., & Guitart, X. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008052 · Cited by 570
Self-citationNeurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist
Kato, K., Hirai, K., Nishiyama, K., Uchikawa, O., Fukatsu, K., Ohkawa, S., Kawamata, Y., Hinuma, S., & Miyamoto, M. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.09.007 · Cited by 539
Millan, M. J., Gobert, A., Lejeune, F., Dekeyne, A., Newman-Tancredi, A., Pasteau, V., Rivet, J.-M., & Cussac, D. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.051797 · Cited by 516
Melatonin is a potent modulator of dopamine release in the retina
Dubocovich, M. L. (1983) · Nature · doi:10.1038/306782a0 · Cited by 510
Self-citationEffects of Melatonin Treatment in Septic Newborns
Gitto, E., Karbownik, M., Reiter, R. J., Tan, D. X., Cuzzocrea, S., Chiurazzi, P., Cordaro, S., Corona, G., Trimarchi, G., & Barberi, I. (2001) · Pediatric Research · doi:10.1203/00006450-200112000-00021 · Cited by 507
The immunoneuroendocrine role of melatonin
Maestroni, G. J. M. (1993) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1993.tb00478.x · Cited by 489
Carrillo‐Vico, A., Calvo, J. R., Abreu, P., Lardone, P. J., García‐Mauriño, S., Reiter, R. J., & Guerrero, J. M. (2004) · The FASEB Journal · doi:10.1096/fj.03-0694fje · Cited by 458
Molecular pharmacology regulation and function of mammalian melatonin receptors
Dubocovich, M. L. (2003) · Frontiers in Bioscience · doi:10.2741/1089 · Cited by 451
Self-citationStructural basis for modulation of a G-protein-coupled receptor by allosteric drugs
Dror, R. O., Green, H. F., Valant, C., Borhani, D. W., Valcourt, J. R., Pan, A. C., Arlow, D. H., Canals, M., Lane, J. R., Rahmani, R., et al. (2013) · Nature · doi:10.1038/nature12595 · Cited by 411
Melatonin receptors: Are there multiple subtypes?
Dubocovich, M. L. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)88978-6 · Cited by 403
Self-citationEvidence for melatonin synthesis in mouse and human bone marrow cells
Conti, A., Conconi, S., Hertens, E., Skwarlo‐Sonta, K., Markowska, M., & Maestroni, G. J. M. (2000) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2000.280401.x · Cited by 379
Melatonin receptors: role on sleep and circadian rhythm regulation
Dubocovich, M. L. (2007) · Sleep Medicine · doi:10.1016/j.sleep.2007.10.007 · Cited by 364
Dubocovich, M. L., Yun, K., Al‐Ghoul, W. M., Benloucif, S., & Masana, M. I. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1211 · Cited by 364
Self-citationRare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes
The Meta-Analysis of Glucose and Insulin-Related Traits Consortium (MAGIC), Bonnefond, A., Clément, N., Fawcett, K., Yengo, L., Vaillant, E., Guillaume, J.-L., Dechaume, A., Payne, F., Roussel, R., et al. (2012) · Nature Genetics · doi:10.1038/ng.1053 · Cited by 363
Self-citationLevoye, A., Dam, J., Ayoub, M. A., Guillaume, J., Couturier, C., Delagrange, P., & Jockers, R. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601193 · Cited by 334
Self-citationDubocovich, M. L., Masana, M. I., Iacob, S., & Sauri, D. M. (1997) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/pl00004956 · Cited by 331
Self-citationAyoub, M. A., Couturier, C., Lucas-Meunier, E., Angers, S., Fossier, P., Bouvier, M., & Jockers, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200729200 · Cited by 322
Self-citationMelatonin Contributes to the Seasonality of Multiple Sclerosis Relapses
Farez, M. F., Mascanfroni, I. D., Méndez-Huergo, S. P., Yeste, A., Murugaiyan, G., Garo, L. P., Balbuena Aguirre, M. E., Patel, B., Ysrraelit, M. C., Zhu, C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.025 · Cited by 318
Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new?
Jockers, R., Maurice, P., Boutin, J. A., & Delagrange, P. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.184 · Cited by 293
Self-citationMode of action of agomelatine: Synergy between melatonergic and 5-HT2Creceptors
Racagni, G., Riva, M. A., Molteni, R., Musazzi, L., Calabrese, F., Popoli, M., & Tardito, D. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.595823 · Cited by 282
Reduced oxidative damage in ALS by high‐dose enteral melatonin treatment
Weishaupt, J. H., Bartels, C., Pölking, E., Dietrich, J., Rohde, G., Poeggeler, B., Mertens, N., Sperling, S., Bohn, M., Hüther, G., et al. (2006) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2006.00377.x · Cited by 282
Development and validation of a melatonin radioimmunoassay using radioiodinated melatonin as tracer
Vakkuri, O., Leppäluoto, J., & Vuolteenaho, O. (1984) · Acta Endocrinologica · doi:10.1530/acta.0.1060152 · Cited by 277
Medeiros, C. A. M., Carvalhedo de Bruin, P. F., Lopes, L. A., Magalhães, M. C., de Lourdes Seabra, M., & Sales de Bruin, V. M. (2007) · Journal of Neurology · doi:10.1007/s00415-006-0390-x · Cited by 269
Zhou, J., Liu, R., Kamphorst, W., Hofman, M. A., & Swaab, D. F. (2003) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2003.00065.x · Cited by 268
The Concise Guide to PHARMACOLOGY 2015/16: Transporters
Alexander, S. P., Kelly, E., Marrion, N., Peters, J. A., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Southan, C., Davies, J. A., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13355 · Cited by 266
Hunt, A. E., Al-Ghoul, W. M., Gillette, M. U., & Dubocovich, M. L. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.1.c110 · Cited by 265
Self-citationMcArthur, A. J., Hunt, A. E., & Gillette, M. U. (1997) · Endocrinology · doi:10.1210/en.138.2.627 · Cited by 262
Olcese, J. M., Cao, C., Mori, T., Mamcarz, M. B., Maxwell, A., Runfeldt, M. J., Wang, L., Zhang, C., Lin, X., Zhang, G., et al. (2009) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00692.x · Cited by 260
von Gall, C., Garabette, M. L., Kell, C. A., Frenzel, S., Dehghani, F., Schumm-Draeger, P.-M., Weaver, D. R., Korf, H.-W., Hastings, M. H., & Stehle, J. H. (2002) · Nature Neuroscience · doi:10.1038/nn806 · Cited by 251
New selective ligands of human cloned melatonin MT1 and MT2 receptors
Audinot, V., Mailliet, F., Lahaye-Brasseur, C., Bonnaud, A., Le Gall, A., Amossé, C., Dromaint, S., Rodriguez, M., Nagel, N., Galizzi, J.-P., et al. (2003) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-003-0751-2 · Cited by 248
Self-citationTargeted Disruption of the Mouse Mel1b Melatonin Receptor
Jin, X., von Gall, C., Pieschl, R. L., Gribkoff, V. K., Stehle, J. H., Reppert, S. M., & Weaver, D. R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.3.1054-1060.2003 · Cited by 240
Ressmeyer, A.-R., Mayo, J. C., Zelosko, V., Sáinz, R. M., Tan, D.-X., Poeggeler, B., Antolín, I., Zsizsik, B. K., Reiter, R. J., & Hardeland, R. (2003) · Redox Report · doi:10.1179/135100003225002709 · Cited by 238
Use of 2-[125I]iodomelatonin to characterize melatonin binding sites in chicken retina.
Dubocovich, M. L., & Takahashi, J. S. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.11.3916 · Cited by 224
Self-citationRajaratnam, S. M., Polymeropoulos, M. H., Fisher, D. M., Roth, T., Scott, C., Birznieks, G., & Klerman, E. B. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61812-7 · Cited by 215
Luzindole (N-0774): a novel melatonin receptor antagonist.
Dubocovich, M. L. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22188-7 · Cited by 210
Self-citationWu, Y.-H., Zhou, J.-N., Van Heerikhuize, J., Jockers, R., & Swaab, D. F. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.06.002 · Cited by 208
Self-citationAyoub, M. A., Levoye, A., Delagrange, P., & Jockers, R. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.000398 · Cited by 207
Self-citationClinical Aspects of Melatonin Intervention in Alzheimers Disease Progression
P. Cardinali, D., M. Furio, A., & I. Brusco, L. (2010) · Current Neuropharmacology · doi:10.2174/157015910792246209 · Cited by 204
Structural diversity in the RGS domain and its interaction with heterotrimeric G protein α-subunits
Soundararajan, M., Willard, F. S., Kimple, A. J., Turnbull, A. P., Ball, L. J., Schoch, G. A., Gileadi, C., Fedorov, O. Y., Dowler, E. F., Higman, V. A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801508105 · Cited by 201
Calcium-dependent modulation by melatonin of the circadian rhythm in malarial parasites.
Hotta, C. T., Gazarini, M. L., Beraldo, F. H., Varotti, F. P., Lopes, C., Markus, R. P., Pozzan, T., & Garcia, C. R. S. (2000) · Nature Cell Biology · doi:10.1038/35017112 · Cited by 198
Self-citationThe Concise Guide to PHARMACOLOGY 2015/16: Voltage‐gated ion channels
Alexander, S. P., Catterall, W. A., Kelly, E., Marrion, N., Peters, J. A., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Southan, C., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13349 · Cited by 195
Faust, R., Garratt, P. J., Jones, R., Yeh, L.-K., Tsotinis, A., Panoussopoulou, M., Calogeropoulou, T., Teh, M.-T., & Sugden, D. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm980684+ · Cited by 187
The Melatonin MT1 Receptor Axis Modulates Mutant Huntingtin-Mediated Toxicity
Wang, X., Sirianni, A., Pei, Z., Cormier, K., Smith, K., Jiang, J., Zhou, S., Wang, H., Zhao, R., Yano, H., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3059-11.2011 · Cited by 186
Melatonin and N-acetylserotonin inhibit leukocyte rolling and adhesion to rat microcirculation
Lotufo, C. M. C., Lopes, C., Dubocovich, M. L., Farsky, S. H. P., & Markus, R. P. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01369-3 · Cited by 184
Self-citationMT1 and MT2 Melatonin Receptors: Ligands, Models, Oligomers, and Therapeutic Potential
Zlotos, D. P., Jockers, R., Cecon, E., Rivara, S., & Witt-Enderby, P. A. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401343c · Cited by 175
Self-citationLaudon, M., G Wade, A., Farmer, M., Harari, G., Fund, N., Nir, T., Frydman-Marom, A., & Zisapel, N. (2014) · Clinical Interventions in Aging · doi:10.2147/cia.s65625 · Cited by 173
Vaněček, J. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb01108.x · Cited by 167
Melatonin inhibits hippocampal long‐term potentiation
Wang, L. M., Suthana, N., Chaudhury, D., Weaver, D. R., & Colwell, C. S. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04408.x · Cited by 160
Muxel, S. M., Lapa, M. A. P. C., Monteiro, A. W. A., Cecon, E., Tamura, E. K., Floeter‐Winter, L. M., & Markus, R. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052010 · Cited by 158
Self-citationIncreased melatonin 1a‐receptor immunoreactivity in the hippocampus of Alzheimer's disease patients
Savaskan, E., Olivieri, G., Meier, F., Brydon, L., Jockers, R., Ravid, R., Wirz‐Justice, A., & Müller-Spahn, F. (2002) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2002.00841.x · Cited by 152
Self-citationHeteromeric MT 1 /MT 2 Melatonin Receptors Modulate Photoreceptor Function
Baba, K., Benleulmi‐Chaachoua, A., Journé, A., Kamal, M. T., Guillaume, J., Dussaud, S., Gbahou, F., Yettou, K., Liu, C., Contreras‐Alcantara, S., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004302 · Cited by 150
Self-citationMelatonin: An underappreciated player in retinal physiology and pathophysiology
Tosini, G., Baba, K., Hwang, C. K., & Iuvone, P. M. (2012) · Experimental Eye Research · doi:10.1016/j.exer.2012.08.009 · Cited by 150
Self-citationMühlbauer, E., Gross, E. C., Labucay, K., Wolgast, S., & Peschke, E. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.01.029 · Cited by 148
Baba, K., Pozdeyev, N. V., Mazzoni, F., Contreras‐Alcantara, S., Liu, C., Kasamatsu, M., Martinez-Merlos, T., Strettoi, E., Iuvone, P. M., & Tosini, G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904400106 · Cited by 146
Self-citationMelatonin uptake through glucose transporters: a new target for melatonin inhibition of cancer
Hevia, D., González‐Menéndez, P., Quirós-González, I., Miar, A., Rodríguez‐García, A., Tan, D. X., Reiter, R. J., Mayo, J. C., & Sainz, R. M. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12210 · Cited by 144
Characterization of a retinal melatonin receptor.
Dubocovich, M. L. (1985) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23458-9 · Cited by 143
Self-citationPharmacological characterization of human recombinant melatonin mt1 and MT2 receptors
Browning, C., Beresford, I. J. M., Fraser, N., & Giles, H. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703130 · Cited by 143
Synthesis of a Novel Series of Tricyclic Indan Derivatives as Melatonin Receptor Agonists
Uchikawa, O., FUKATSU, K., Tokunoh, R., Kawada, M., Matsumoto, K., Imai, Y., Hinuma, S., Kato, K., Nishikawa, H., Hirai, K., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0201159 · Cited by 143
Antagonism of serotonergic 5‐HT2A/2Creceptors: mutual improvement of sleep, cognition and mood?
Landolt, H., & Wehrle, R. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06718.x · Cited by 142
Zhang, Y., Cook, A., Kim, J., Baranov, S. V., Jiang, J., Smith, K., Cormier, K., Bennett, E., Browser, R. P., Day, A. L., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.03.008 · Cited by 140
Tosini, G., Owino, S., Guillaume, J., & Jockers, R. (2014) · BioEssays · doi:10.1002/bies.201400017 · Cited by 139
Self-citationGerdin, M. J., Masana, M. I., Rivera-Bermudez, M. A., Hudson, R. L., Earnest, D. J., Gillette, M. U., & Dubocovich, M. L. (2004) · The FASEB Journal · doi:10.1096/fj.03-1339com · Cited by 137
Self-citationRemoval of Melatonin Receptor Type 1 Induces Insulin Resistance in the Mouse
Contreras‐Alcantara, S., Baba, K., & Tosini, G. (2010) · Obesity · doi:10.1038/oby.2010.24 · Cited by 136
Self-citationMelatonin Transmits Photoperiodic Signals through the MT1 Melatonin Receptor
Yasuo, S., Yoshimura, T., Ebihara, S., & Korf, H. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0145-09.2009 · Cited by 134
Convergence of Melatonin and Serotonin (5-HT) Signaling at MT2/5-HT2C Receptor Heteromers
Kamal, M. T., Gbahou, F., Guillaume, J., Daulat, A. M., Benleulmi‐Chaachoua, A., Luka, M., Chen, P. B., Anaraki, D. K., Baroncini, M., la Cour, C. M., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.559542 · Cited by 134
Self-citationDubocovich, M. L., Hudson, R. L., Sumaya, I. C., Masana, M. I., & Manna, E. (2005) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2005.00230.x · Cited by 129
Self-citationOchoa‐Sanchez, R., Comai, S., Lacoste, B., Bambico, F. R., Domínguez-López, S., Spadoni, G., Rivara, S., Bedini, A., Angeloni, D., FRASCHINI, F., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2676-11.2011 · Cited by 128
Markus, R. P., Cecon, E., & Lapa, M. A. P. C. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140610979 · Cited by 128
Self-citationImpaired hippocampal long-term potentiation in melatonin MT2 receptor-deficient mice
Larson, J., Jessen, R. E., Uz, T., Arslan, A. D., Kürtüncü, M., Imbesi, M., & Manev, H. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.09.040 · Cited by 127
Do orphan G‐protein‐coupled receptors have ligand‐independent functions?
Levoye, A., Dam, J., Ayoub, M. A., Guillaume, J., & Jockers, R. (2006) · EMBO Reports · doi:10.1038/sj.embor.7400838 · Cited by 123
Self-citationPontes, G. N., Cardoso, E. C., Carneiro-Sampaio, M. M. S., & Markus, R. P. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00487.x · Cited by 122
Self-citationComai, S., Ochoa‐Sanchez, R., & Gobbi, G. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.01.008 · Cited by 122
Melatonin Regulates the Viability and Differentiation of Rat Midbrain Neural Stem Cells
Kong, X., Li, X., Cai, Z., Yang, N., Liu, Y., Shu, J., Pan, L., & Zuo, P. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9212-7 · Cited by 120
Shin, I., Shin, N., Park, J., Jeon, C., Hong, J., Kwon, O., Kim, J., Lee, I., Kim, J., Oh, S., et al. (2014) · Journal of Pineal Research · doi:10.1111/jpi.12192 · Cited by 113
Molinari, E. J., North, P. C., & Dubocovich, M. L. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00870-5 · Cited by 110
Self-citationAsymmetry of GPCR oligomers supports their functional relevance
Maurice, P., Kamal, M. T., & Jockers, R. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.05.006 · Cited by 110
Self-citationChaste, P., Clément, N., Mercati, O., Guillaume, J., Delorme, R., Goubran‐Botros, H., Pagan, C., Périvier, S., Scheid, I., Nygren, G., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011495 · Cited by 108
Self-citationMelatonin MT1 and MT2 receptor expression in Parkinson's disease.
Adi, N., Mash, D. C., Ali, Y., Singer, C., Shehadeh, L. A., & Papapetropoulos, S. (2010) · PubMed · Cited by 106
Zhang, W., Chen, X., Su, S., Jia, Q., Ding, T., Zhu, Z., & Zhang, T. (2015) · Neurological Sciences · doi:10.1007/s10072-015-2357-0 · Cited by 105
Stumpf, I., Mühlbauer, E., & Peschke, E. (2008) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2008.00593.x · Cited by 99
Sengupta, A., Baba, K., Mazzoni, F., Pozdeyev, N. V., Strettoi, E., Iuvone, P. M., & Tosini, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024483 · Cited by 97
Self-citationProvasi, D., Artacho, M. C., Negri, A., Mobarec, J. C., & Filizola, M. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002193 · Cited by 95
Johnston, J. D., & Skene, D. J. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0119 · Cited by 95
Rhythms in clock proteins in the mouse pars tuberalis depend on MT1 melatonin receptor signalling
Jilg, A., Moek, J., Weaver, D. R., Korf, H., Stehle, J. H., & von Gall, C. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04485.x · Cited by 94
Daulat, A. M., Maurice, P., Froment, C., Guillaume, J., Broussard, C., Monsarrat, B., Delagrange, P., & Jockers, R. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m600298-mcp200 · Cited by 93
Self-citationO’Neal-Moffitt, G., Delic, V., Bradshaw, P. C., & Olcese, J. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0027-6 · Cited by 92
Pinato, L., Cruz‐Machado, S. D. S., Franco, D. G., Campos, L. M. G., Cecon, E., Fernandes, P. A. C. M., Bittencourt, J. C., & Markus, R. P. (2013) · Brain Structure and Function · doi:10.1007/s00429-013-0686-4 · Cited by 88
Self-citationRivara, S., Lodola, A., Mor, M., Bedini, A., Spadoni, G., Lucini, V., Pannacci, M., FRASCHINI, F., Scaglione, F., Ochoa‐Sanchez, R., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm700957j · Cited by 87
Suprachiasmatic Nucleus Neuropeptide Expression in Patients with Huntington's Disease
van Wamelen, D. J., Aziz, N. A., Anink, J. J., van Steenhoven, R., Angeloni, D., FRASCHINI, F., Jockers, R., Roos, R. A. C., & Swaab, D. F. (2012) · SLEEP · doi:10.5665/sleep.2314 · Cited by 83
Self-citationZisapel, N., & Laudon, M. (1982) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(82)91437-1 · Cited by 80
Naskar, A., Prabhakar, V., Singh, R. P., Dutta, D., & Mohanakumar, K. P. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12212 · Cited by 79
Long-Lasting Priming of Endothelial Cells by Plasma Melatonin Levels
Tamura, E. K., Fernandes, P. A. C. M., Marçola, M., Cruz‐Machado, S. D. S., & Markus, R. P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013958 · Cited by 77
Self-citationRivara, S., Lorenzi, S., Mor, M., Plazzi, P. V., Spadoni, G., Bedini, A., & Tarzia, G. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm048956y · Cited by 77
Peng, C., Hu, J., Liu, D., Hong, X., Wu, Y., Zhu, L., & Wang, J. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.12.010 · Cited by 76
Pfeffer, M., Rauch, A., Korf, H., & von Gall, C. (2012) · Chronobiology International · doi:10.3109/07420528.2012.667859 · Cited by 75
Owino, S., Contreras‐Alcantara, S., Baba, K., & Tosini, G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148214 · Cited by 74
Self-citationPhotoperiod Programs Dorsal Raphe Serotonergic Neurons and Affective Behaviors
Green, N. H., Jackson, C. R., Iwamoto, H., Tackenberg, M. C., & McMahon, D. G. (2015) · Current Biology · doi:10.1016/j.cub.2015.03.050 · Cited by 73
Legros, C., Chesneau, D., Boutin, J. A., Barc, C., & Malpaux, B. (2014) · Journal of Neuroendocrinology · doi:10.1111/jne.12134 · Cited by 73
Lapa, M. A. P. C., Tamura, E. K., Salustiano, E. M. A., & Markus, R. P. (2013) · Journal of Pineal Research · doi:10.1111/jpi.12066 · Cited by 72
Self-citationLiu, D., Wei, N., Man, H.-Y., Lu, Y., Lq, Z., & Wang, J.-Z. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.195 · Cited by 70
Chaste, P., Clement, N., Botros, H. G., Guillaume, J.-L., Konyukh, M., Pagan, C., Scheid, I., Nygren, G., Anckarsäter, H., Rastam, M., et al. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00902.x · Cited by 67
Self-citationZisapel, N., Egozi, Y., & Laudon, M. (2008) · Neuroendocrinology · doi:10.1159/000124062 · Cited by 67
Design and Synthesis of Naphthalenic Dimers as Selective MT1Melatoninergic Ligands
Descamps‐Francois, C., Yous, S., Chavatte, P., Audinot, V., Bonnaud, A., Boutin, J. A., Delagrange, P., Bennejean, C., Renard, P., & Lesieur, D. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0255872 · Cited by 66
Self-citationDesign of subtype selective melatonin receptor agonists and antagonists
Sugden, D., Yeh, L.-K., & Teh, M. (1999) · annales de biologie animale biochimie biophysique · doi:10.1051/rnd:19990306 · Cited by 65
Melatonin synthesized by Jurkat human leukemic T cell line is implicated in IL‐2 production
Lardone, P. J., Carrillo‐Vico, A., Naranjo, M. C., de Felipe, B., Vallejo, A., Karasek, M., & Guerrero, J. M. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20461 · Cited by 65
Karamitri, A., Renault, N., Clément, N., Guillaume, J., & Jockers, R. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1101 · Cited by 63
Self-citationCecon, E., Chen, M., Marçola, M., Fernandes, P. A. C. M., Jockers, R., & Markus, R. P. (2015) · The FASEB Journal · doi:10.1096/fj.14-265678 · Cited by 63
Self-citationMuxel, S. M., Laranjeira‐Silva, M. F., Carvalho‐Sousa, C. E., Floeter‐Winter, L. M., & Markus, R. P. (2016) · Journal of Pineal Research · doi:10.1111/jpi.12321 · Cited by 60
Self-citationSpadoni, G., Bedini, A., Lucarini, S., Mari, M., Caignard, D., Boutin, J. A., Delagrange, P., Lucini, V., Scaglione, F., Lodola, A., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01066 · Cited by 59
Self-citationBenleulmi‐Chaachoua, A., Chen, L., Sokolina, K., Wong, V., Jurišica, I., Emerit, M. B., Darmon, M. C., Espin, A., Štagljar, I., Tafelmeyer, P., et al. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12294 · Cited by 59
Self-citationTasimelteon: A selective and unique receptor binding profile
Lavedan, C. N., Forsberg, M. A., & Gentile, A. J. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.12.004 · Cited by 58
Neuroendocrine control of photoperiodic changes in immune function
Weil, Z. M., Borniger, J. C., Cissé, Y. M., Salloum, B. A., & Nelson, R. J. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.10.001 · Cited by 58
Urinary 6-sulfatoxymelatonin level in age-related macular degeneration patients.
Rosen, R. B., Hu, D., Perez, V., Tai, K. W., Yu, G., Chen, M., Tone, P., McCormick, S. A., & Walsh, J. (2009) · PubMed Central · Cited by 58
Functional melatonin receptors and metabolic coupling in cultured chick astrocytes
Adachi, A. A., Natesan, A. K., Whitfield‐Rucker, M. G., Weigum, S. E., & Cassone, V. M. (2002) · Glia · doi:10.1002/glia.10109 · Cited by 57
Melatonin attenuates L eishmania (L.) amazonensisinfection by modulating arginine metabolism
Laranjeira‐Silva, M. F., Zampieri, R. A., Muxel, S. M., Floeter‐Winter, L. M., & Markus, R. P. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12279 · Cited by 56
Self-citationSleep-promoting action of IIK7, a selective MT2 melatonin receptor agonist in the rat
Fisher, S. P., & Sugden, D. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.04.005 · Cited by 55
Contreras‐Alcantara, S., Baba, K., & Tosini, G. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.02.056 · Cited by 55
Self-citationThe Role of Melatonin in Multiple Sclerosis, Huntington's Disease and Cerebral Ischemia
Escribano, B. M., Colín-González, A. L., Santamaría, A., & Túnez, I. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666140806160400 · Cited by 55
Recent Progress in the Development of Agonists and Antagonists for Melatonin Receptors
Zlotos, D. P. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712801323153 · Cited by 54
Self-citationMULCHAHEY, J. J., Goldwater, D. R., & Zemlan, F. P. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.03.023 · Cited by 53
Ebisawa, T., Kajimura, N., Uchiyama, M., Katoh, M., Sekimoto, M., Watanabe, T., Ozeki, Y., Ikeda, M., Jodoi, T., Sugishita, M., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1308 · Cited by 52
Savaskan, E., Schnitzler, C., Schroder, C. M., Cajochen, C., Müller-Spahn, F., & Wirz‐Justice, A. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705006036 · Cited by 49
Domínguez-Alonso, A., Valdés‐Tovar, M., Solís‐Chagoyán, H., & Benítez‐King, G. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16011907 · Cited by 49
Galijatovic, E. A. A., Holst, B., Sparsø, T., Grarup, N., Banasik, K., Holmkvist, J., Jørgensen, T., Borch‐Johnsen, K., Egerod, K. L., Lauritzen, T., et al. (2010) · Diabetes · doi:10.2337/db09-1757 · Cited by 46
Melatonin Entrains PER2::LUC Bioluminescence Circadian Rhythm in the Mouse Cornea
Baba, K., Davidson, A. J., & Tosini, G. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-17124 · Cited by 46
Self-citationOrtíz, G. G., Pacheco-Moisés, F. P., Gómez-Rodríguez, V. M., González-Renovato, E. D., Torres-Sánchez, E. D., & Anguiano, A. C. R. (2013) · Metabolic Brain Disease · doi:10.1007/s11011-013-9416-0 · Cited by 43
Mutagenesis studies of the human MT2 melatonin receptor
Gerdin, M. J., Mseeh, F., & Dubocovich, M. L. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00239-9 · Cited by 41
Self-citationRevenga, M. D. L. F., Fernández‐Sáez, N., Herrera‐Arozamena, C., Morales-Garcia, J. A., Alonso‐Gil, S., Pérez‐Castillo, A., Caignard, D., Rivara, S., & Rodrı́guez-Franco, M. I. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00245 · Cited by 41
Cone Viability Is Affected by Disruption of Melatonin Receptors Signaling
Gianesini, C., Hiragaki, S., Laurent, V., Hicks, D., & Tosini, G. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-18235 · Cited by 41
Self-citationGenetic deletion of MT1/MT2 melatonin receptors enhances murine cognitive and motor performance
O’Neal-Moffitt, G., Pilli, J., Kumar, S. S., & Olcese, J. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.07.018 · Cited by 40
Important amino acids for the function of the human MT1 melatonin receptor
Kokkola, T., Foord, S. M., Watson, M.-A., Vakkuri, O., & Laitinen, J. T. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00113-8 · Cited by 40
Mini, L. J., Wang‐Weigand, S., & Zhang, J. (2007) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2007.09.004 · Cited by 40
Tchekalarova, J. D., Nenchovska, Z., Atanasova, D., Atanasova, M., Kortenska, L., Stefanova, M. O., Alova, L. G., & Lazarov, N. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.12.043 · Cited by 40
Vincent, L., Cohen, W., Delagrange, P., Boutin, J. A., & Nosjean, O. (2010) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2010.00746.x · Cited by 39
Self-citationSharma, S., & Haldar, C. (2006) · International Journal of Radiation Biology · doi:10.1080/09553000600774105 · Cited by 39
Ettaoussi, M., Sabaouni, A., Rami, M., Boutin, J. A., Delagrange, P., Renard, P., Spedding, M., Caignard, D., Berthelot, P., & Yous, S. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.01.027 · Cited by 38
Self-citationNew Radioligands for Describing the Molecular Pharmacology of MT1 and MT2 Melatonin Receptors
Legros, C., Matthey, U., Grelak, T., PEDRAGOSA‐MOREAU, S., Hassler, W. H., Yous, S., Thomas, E., Suzenet, F., Folléas, B., Lefoulon, F., et al. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14058948 · Cited by 37
Self-citationMaurice, P., Daulat, A. M., Broussard, C., Mozo, J., Clary, G., Hotellier, F., Chafey, P., Guillaume, J., Ferry, G., Boutin, J. A., et al. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700435-mcp200 · Cited by 36
Self-citationConway, S., Mowat, E. S., Drew, J. E., Barrett, P., Delagrange, P., & Morgan, P. J. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4722 · Cited by 35
Self-citationAutomated video analysis system reveals distinct diurnal behaviors in C57BL/6 and C3H/HeN mice
Adamah‐Biassi, E. B., Stepien, I., Hudson, R. L., & Dubocovich, M. L. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.01.003 · Cited by 35
Self-citationBlocking of melatonin synthesis and MT1 receptor impairs the activation of Jurkat T cells
Lardone, P. J., Rubio, A., Cerrillo, I., Gómez-Corvera, A., Carrillo‐Vico, A., Sánchéz‐Hidalgo, M., Guerrero, J. M., Riejos, P. F., Sánchez‐Margalet, V., & Molinero, P. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0374-y · Cited by 35
Evely, K. M., Hudson, R. L., Dubocovich, M. L., & Haj‐Dahmane, S. (2016) · Synapse · doi:10.1002/syn.21892 · Cited by 35
Self-citationRivara, S., Pala, D., Lodola, A., Mor, M., Lucini, V., Dugnani, S., Scaglione, F., Bedini, A., Lucarini, S., Tarzia, G., et al. (2012) · ChemMedChem · doi:10.1002/cmdc.201200303 · Cited by 34
Pala, D., Beuming, T., Sherman, W., Lodola, A., Rivara, S., & Mor, M. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci4000147 · Cited by 34
Hutchinson, A. J., Hudson, R. L., & Dubocovich, M. L. (2012) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2012.01010.x · Cited by 32
Self-citationMazna, P., Obšilová, V., Jelínková, I., Balík, A., Berka, K., Sovová, Ž., Ettrich, R. H., Svoboda, P., Obšil, T., & Teisinger, J. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02758.x · Cited by 32
Prada, C. M., Udin, S. B., Wiechmann, A. F., & Zhdanova, I. V. (2005) · Journal of Neurophysiology · doi:10.1152/jn.01286.2004 · Cited by 32
Hu, Y., Ho, M. K. C., Chan, K. H., New, D. C., & Wong, Y. H. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.02.084 · Cited by 32
Zlotos, D. P., Attia, M. I., Julius, J., Sethi, S., & Witt‐Enderby, P. A. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm800974d · Cited by 31
Self-citationSynthesis of 3-phenylnaphthalenic derivatives as new selective MT2 melatoninergic ligands
Durieux-Poissonnier, S., Ettaoussi, M., Pérès, B., Boutin, J. A., Audinot, V., Bennejean, C., Delagrange, P., Caignard, D. H., Renard, P., Berthelot, P., et al. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.08.052 · Cited by 31
Self-citationMésangeau, C., Pérès, B., Descamps‐Francois, C., Chavatte, P., Audinot, V., Coumailleau, S., Boutin, J. A., Delagrange, P., Bennejean, C., Renard, P., et al. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.04.008 · Cited by 29
Self-citationTherapeutic Strategies for Circadian Rhythm and Sleep Disturbances in Huntington Disease
van Wamelen, D. J., Roos, R. A. C., & Aziz, N. A. (2015) · Neurodegenerative Disease Management · doi:10.2217/nmt.15.45 · Cited by 28
Alternative Radioligands for Investigating the Molecular Pharmacology of Melatonin Receptors
Legros, C., Brasseur, C., Delagrange, P., Ducrot, P., Nosjean, O., & Boutin, J. A. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.229989 · Cited by 27
Self-citation5‐MCA‐NAT does not act through NQO2 to reduce intraocular pressure in New‐Zealand white rabbit
Alarma‐Estrany, P., Crooke, A., & Pintor, J. J. (2009) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00702.x · Cited by 26
Homology modeling of MT1 and MT2 receptors
Farce, A., Chugunov, A. O., Logé, C., Sabaouni, A., Yous, S., Dilly, S., Renault, N., Vergoten, G., Efremov, R. G., & Lesieur, D. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2007.12.001 · Cited by 25
Self-citationRawashdeh, O., Hudson, R. L., Stepien, I., & Dubocovich, M. L. (2010) · Chronobiology International · doi:10.3109/07420528.2010.532894 · Cited by 25
Self-citationClough, S. J., Hutchinson, A. J., Hudson, R. L., & Dubocovich, M. L. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.04.049 · Cited by 24
Self-citationPromising Role of Melatonin as Neuroprotectant in Neurodegenerative Pathology
Joshi, N., Biswas, J., Nath, C., & Singh, S. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8865-8 · Cited by 24
Johnston, J. M., & Filizola, M. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-7423-0_6 · Cited by 22
Melatonin inhibits granulocyte adhesion to ICAM via MT3/QR2 and MT2 receptors
Černyšiov, V., Mauricas, M., & Girkontaitė, I. (2015) · International Immunology · doi:10.1093/intimm/dxv035 · Cited by 19
Chen, X., Li, X., Du, Z., Shi, W., Yao, Y., Wang, C., He, K., & Hao, A. (2014) · Journal of Pineal Research · doi:10.1111/jpi.12153 · Cited by 17
Spadoni, G., Bedini, A., Orlando, P., Lucarini, S., Tarzia, G., Mor, M., Rivara, S., Lucini, V., Pannacci, M., & Scaglione, F. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.06.063 · Cited by 17
N1-linked melatonin dimers as bivalent ligands targeting dimeric melatonin receptors
Journé, A., Habib, S. A. M., Dodda, B. R., Morcos, M. N. F., Sadek, M. S., Tadros, S. A. A., Witt‐Enderby, P. A., Jockers, R., & Zlotos, D. P. (2014) · MedChemComm · doi:10.1039/c4md00079j · Cited by 16
Self-citationZefirova, O. N., Baranova, T. Y., Ivanova, A. A., Ivanov, A. A., & Zefirov, N. S. (2011) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2011.02.002 · Cited by 14
Sampaio, L. D. F. S., Mesquita, F. P., de Sousa, P. R. M., Lameira, J., & Alves, C. N. (2014) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2014.09.001 · Cited by 12
Zlotos, D. P., Riad, N. M., Osman, M. B., et al. (2015) · MedChemComm · doi:10.1039/c5md00190k · Cited by 11
Self-citationSheynzon, P., & Korf, H. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.08.016 · Cited by 9
Exon Sequencing of G Protein-Coupled Receptor Genes and Perspectives for Disease Treatment
Karamitri, A., & Jockers, R. (2013) · Methods in pharmacology and toxicology · doi:10.1007/978-1-62703-779-2_17 · Cited by 8
Self-citationComputational Study on the Kinetics and Mechanism of the Carbaryl + OH Reaction
Zavala‐Oseguera, C., Galano, A., & Merino, G. (2014) · The Journal of Physical Chemistry A · doi:10.1021/jp507244s · Cited by 5
Cited by
Melatonin Synthesis and Function: Evolutionary History in Animals and Plants
Zhao, D., Yu, Y., Shen, Y., Liu, Q., Zhao, Z., Sharma, R., & Reiter, R. J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00249 · Cited by 689
A brief review about melatonin, a pineal hormone
Amaral, F. G. D., & Cipolla-Neto, J. (2018) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000066 · Cited by 370
Tarocco, A., Caroccia, N., Morciano, G., Wieckowski, M. R., Ancora, G., Garani, G., & Pinton, P. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1556-7 · Cited by 299
Virtual discovery of melatonin receptor ligands to modulate circadian rhythms
Stein, R. M., Kang, H. J., McCorvy, J. D., Glatfelter, G. C., Jones, A. J., Che, T., Slocum, S., Huang, X.-P., Savych, O., Moroz, Y. S., et al. (2020) · Nature · doi:10.1038/s41586-020-2027-0 · Cited by 298
Self-citationTryptophan in health and disease
(2020) · Advances in Clinical Chemistry · doi:10.1016/bs.acc.2019.08.005 · Cited by 294
Metadata
- Authors
- Jockers, R., Delagrange, P., Dubocovich, M. L., Markus, R. P., Renault, N., Tosini, G., Cecon, E., & Zlotos, D. P.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2016-08-08
- Volume
- 173
- Issue
- 18
- Pages
- 2702-2725
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2442143867
- Cited by
- 422
- References
- 192
- FWCI
- 18.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.